Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery.
- Published in:
- ChemistryOpen, 2019, v. 8, n. 6, p. 737, doi. 10.1002/open.201900110
- By:
- Publication type:
- Article
Works by Pina, Arianna
Results: 7
1
2
Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and α<sub>V</sub>β<sub>3</sub>‐Integrin Ligands for Tumor Targeting.
- Published in:
- European Journal of Organic Chemistry, 2018, v. 2018, n. 23, p. 2902, doi. 10.1002/ejoc.201800447
- By:
- Publication type:
- Article
3
Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake.
- Published in:
- Chemistry - A European Journal, 2020, v. 26, n. 33, p. 7492, doi. 10.1002/chem.202001115
- By:
- Publication type:
- Article
4
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin‐Targeted Conjugate.
- Published in:
- Chemistry - A European Journal, 2019, v. 25, n. 7, p. 1696, doi. 10.1002/chem.201805447
- By:
- Publication type:
- Article
5
Frontispiece: Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α<sub>V</sub>β<sub>3</sub>.
- Published in:
- Chemistry - A European Journal, 2017, v. 23, n. 58, p. n/a, doi. 10.1002/chem.201703093
- By:
- Publication type:
- Article
6
Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α<sub>V</sub>β<sub>3</sub>.
- Published in:
- Chemistry - A European Journal, 2017, v. 23, n. 58, p. 14410, doi. 10.1002/chem.201703093
- By:
- Publication type:
- Article
7
Tumor Targeting with an isoDGR-Drug Conjugate.
- Published in:
- Chemistry - A European Journal, 2017, v. 23, n. 33, p. 7910, doi. 10.1002/chem.201701844
- By:
- Publication type:
- Article